Investigational Drug Study for Adolescents and Adults with Fragile X Syndrome


What are we studying?

This study is sponsored by Neuren Pharmaceuticals and is being conducted by approximately 5 research centers. The purpose of the study is to evaluate whether an investigational drug is safe and effective for the treatment of the symptoms of Fragile X.

Who can participate?

    • Males between 14 and 40 years old
    • Diagnosis of Fragile X syndrome
    • Exhibits behaviors such as: repetitive or stereotypical behaviors, anxiety, social withdrawal, sensory over- sensitivity, cognitive difficulties

How will participants be compensated?

For each visit to the office, a small payment will be offered to offset travel expenses. The investigational drug and all study-related evaluations are provided free of charge.

For more information, contact CANDI at 774-455-4100 or

A PDF flyer is available for this study.

Docket # H-00003719

LogoInvesting in the future...helping kids and families.

▴ Back To Top